The United States Patent and Trademark Office (USPTO) has renewed the trademark registration (TM87186405) for the mark OPTILUME, which is associated with drug-coated balloon catheters. The renewal was effective March 20, 2026, with the original filing date being September 28, 2016. This is an administrative action confirming the continued protection of the trademark.

This renewal is primarily an intellectual property matter and does not impose new regulatory obligations on manufacturers or healthcare providers. Compliance officers should note that the trademark remains active, ensuring continued brand protection for the specified medical device. No immediate actions are required from regulated entities beyond acknowledging the trademark's continued validity.